The US Food and Drug Administration (FDA) has fast-tracked a promising new gene therapy, KB707, which is inhaled as a fine mist for the targeted treatment of advanced or metastatic non-small-cell lung cancer.
[News] FDA fast-tracks first inhalable gene therapy for lung cancer
The Lancet Oncology | | Elizabeth Gourd
Topics: lung-cancer, blood-cancer, new-technology, research